- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01370759
Feasibility Study to Evaluate the Performance of Flocculation-Adsorption System for Colon Cleansing Enhancement (RD-400)
July 29, 2019 updated by: Medtronic - MITG
Flocculation-Adsorption System for Colon Cleansing Enhancement: A Feasibility Study
The purpose of this study is to demonstrate feasibility of enhancing colon cleansing.
Study Overview
Detailed Description
To ensure the success of a PillCamTM Colon examination, as standard practice, patients are requested to adhere to a bowel preparation procedure.
The study is designed to evaluate the performance and contribution of a flocculation-adsorption system to colon cleansing.
Study Type
Interventional
Enrollment (Actual)
81
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Rambam Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
23 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject's age is between 23-75 years.
- Subject is healthy.
- Subject agrees to sign the Informed Consent Form
Exclusion Criteria:
- Contraindication to capsule endoscopy
- Contraindication or allergy to any of the products and materials used for bowel preparation
- Subject is not able to provide written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Colon-targeted cleaning capsule
|
Capsules containing the tested materials aimed to improve colon cleansing
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cleansing grading
Time Frame: within 10 days
|
within 10 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Distribution of time
Time Frame: within 10 days
|
within 10 days
|
|
GI tract segment of capsule disintegration
Time Frame: within 10 days
|
within 10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ian Gralnek, MD, Rambam Health Care Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
June 9, 2011
First Submitted That Met QC Criteria
June 9, 2011
First Posted (Estimate)
June 10, 2011
Study Record Updates
Last Update Posted (Actual)
July 31, 2019
Last Update Submitted That Met QC Criteria
July 29, 2019
Last Verified
April 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CTIL - RD-400
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.